Epidemiologic Study of Tuberculosis in Kerman City during 2011 – 2015

Authors

Abstract

Background: Tuberculosis is one of the most important infectious diseases causing numerous social and economic problems. Understanding the epidemiology of tuberculosis and its related indices is one of the most important strategies for the prevention of this disease and accelerating the process of achieving sustainable development goals.
 
Methods: In this cross-sectional and descriptive-analytic study, data were collected by a researcher-made check list and using the recorded data in the Tuberculosis surveillance system during 2011 to 2015. Data analysis was done through SPSS20 and using descriptive statistics, frequency distribution and Chi-square test.
 
Results: A total number of 674 cases were studied of which, 87% were pulmonary and the rest were extra-pulmonary. The disease showed a decreasing trend during the years of study. The incidence rate of drug-resistant tuberculosis was about 10 per ten thousand. Approximately, 4% of patients had recurrent disease during the years of study. In pulmonary tuberculosis, the risk of recurrence and resistance was significantly higher compared to extra-pulmonary tuberculosis (P= 0.001). From all patients, about 4% had previous treatment for TB and 2.5% were HIV-positive.
 
Conclusion: Indicators of tuberculosis in the city of Kerman in comparison with the indicators set by the World Health Organization were acceptable; however, due to the geographical location of Kerman that its closeness to eastern borders a stronger surveillance system is required.

Keywords

References

1. Nasehi M, Mirhaghghani L. Guidelines for combating TB. Disease Management Center of Health Ministry. Tehran: Arjmand; 2010. Persian 2. Rom WN, Garay SM. Tuberculosis. 2th ed. USA: LittleBrown and Company; 1996. 3. Velayati AL, Masjedi MR, Ziazarifi A, Tabatabai J. Tuberculosis clinical pathology. 1thed. Tehran: Publications Office of the Islamic Culture Publication; 1994. Persian 4. Centers for Disease Control and Prevention. Core Curriculum on Tuberculosis: What the Clinician Should Know; 2013. [cited 2016 Nov 3]. Available from: https://www.cdc.gov/tb/education/corecurr/pdf/corecurr_all.pdf 5. Azizi F, Hatami H, Janghorbani M. Epidemiology and control of common diseases in Iran. Tehran: Eshtiagh; 2000. Persian 6. Hatami H, Razavi SM, Eftekhar Ardabili H, Majlesi F. Text Book of Public Health. 2th ed. Tehran: Arjmand; 2007. Persian 7. World Health Organization (WHO). Global Tuberculosis Control: Surveillance, Planning, Financing: WHO report 2007 [cited 2016 Nov 3]. Available from:http://apps.who.int/iris/bitstream/handle/10665/43629/9789241563141_eng.pdf?sequence=1&isAllowed=y 8. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282(7):677-86. 10. Maher D, Raviglione M, Global Epidemiology of Tuberculosis. Clinics in Chest Medicine 2005; 26(2):167-82. 11. World Health Organization (WHO). Global Tuberculosis Control Epidemiology, Strategy, Financing: WHO report 2009. [cited 2016 Jun 8] Available from: https://reliefweb.int/sites/reliefweb.int/files/resources/878BDA5E2504C9F449257584001B5E60-who_mar2009.pdf 12. Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, Glaziou P, et al. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 2008;8(4):233-43. 13. World Health Organization (WHO). Global Tuberculosis Control: Surveillance, Planning, Financing: WHO report 2008 [cited 2016 Jun 8]. http://www.unaids.org/sites/default/files/media_asset/who2008globaltbreport_en_0.pdf 14. Ghaderi E, Eftekhar H, Rahimi A, Esmaiili N. Epidemiologic study of 387 pulmonary tuberculosis patients in Kordestan province (Iran) between 2000-2001. The 14th Iranian Congress of Infectious Diseases and Tropical Medicine; 2005 Dec 18-21; Tehran: Office of Political Studies, Ministry of Foreign Affairs; 2005. 15. Mirhaqqani L, Nasehi M. National Guideline for fighting tuberculosis. Ministry of Health and Medical Education, Infectious Disease Management Center. 2th ed. Tehran: Andishmand; 2011. 16. Metanat M, Sharifi-Mood B, Alavi-Naini R, Aminianfar M. The epidemiology of tuberculosis in recent years: Reviewing the status in south-eastern Iran. Zahedan Journal of Research in Medical Sciences 2012;13(9):1-7. Persian 17. Ahmad-Rajabi R, Abazari F. Epidemiology of tuberculosis in Bam 1995-2002. Hormozgan Medical Journal 2002; 6(3):28-4. Persian 18. Sofian M, Zarinfar N, Mirzaee M, Moosavi nejad A. Epidemiology of tuberculosis in Arak, Iran. Koomesh 2009;10(4):261-6. Persian 19. Moeini L. Epidemiological study of clinical symptoms and paraclinical signs, tuberculosis patients hospitalized in Vali-Asr hospital (May 97-8). Journal of Arak University of Medical Sciences 2002; 18(5): 37-41. Persian. 20. Yousefi R, Bashiriyan S, Mohamadtaheri R. A study on radiologic findings, clinical signs and PPD tests in sputum positive patients in Hamadan during 1995-1999. Scientific Journal of Kurdistan University of Medical Sciences 2000; 4(3): 24-8. Persian 21. Moosazadeh M, Khanjani N, Nasehi M, Bahrampour A. The status of the surveillance system of groups at risk of tubercolosis in Iran: a qualitative study. Journal of Health & Development 2016; 5(1):24-44. Persian 22. Nasehi MM, Moosazadeh M, Amiresmaeili MR, Parsaee MR, Nezammahalleh A. The epidemiology of factors associated with screening and treatment outcomes of patients with smear positive pulmonary tuberculosis: a population-based study. Journal of Mazandaran University of Medical Sciences 2012;21(1):9-18. Persian 23. Mohammadpour A, Matlabi M, Fani MJ, Shams H. Epidemiology of Tuberculosis disease during 1372-80 in Gonabad city. Ofogh-e-Danesh 2002; 8(1): 45-51. Persian
Health and Development Journal
Volume 7, Issue 3
November 2018
Pages 218-226

Files

History

  • Receive Date: 24 August 2020
  • Revise Date: 25 April 2024
  • Accept Date: 24 August 2020

Share

How to cite

Statistics